Literature DB >> 6432979

Mucoepidermoid carcinoma: ultrastructural and histogenetic aspects.

I Dardick, D Daya, J Hardie, A W van Nostrand.   

Abstract

Ultrastructural examination of 6 mucoepidermoid carcinomas (4 from parotid salivary gland and 2 from lung) was used to investigate tumor cell types, their interrelationship, histogenetic aspects and factors involved in the multiplicity of histological patterns in this tumor. On the basis of light-microscopic cellular features, mucoepidermoid carcinomas are generally thought to be formed by 3 principal cell types, mucinous, squamous and intermediate. However, low-magnification electron micrographs reveal that there are 2 basic tumor-cell types interpreted as modified luminal epithelial and myoepithelial cells. Both cell types may independently show a range of fine structural modification and organizational arrangement. Luminal epithelial cells have varying degrees of mucin production and lumen formation in some regions, while modification of these cells is one mechanism for squamoid and frankly squamous appearances in other areas. Preferential proliferation of the second type of tumor cell aligned on the outer aspect of luminal epithelial cells is responsible for the development of isomorphic regions composed of intermediate cells. Squamous metaplasia can also occur in relationship to these latter cells. Based on these observations and recent ultrastructural and histochemical studies of salivary gland tumors, it is suggested that, in addition to the excretory duct, neoplastically altered cells in the acinar-intercalated duct region must be considered as a potential source for the development of mucoepidermoid carcinomas.

Entities:  

Mesh:

Year:  1984        PMID: 6432979     DOI: 10.1111/j.1600-0714.1984.tb01433.x

Source DB:  PubMed          Journal:  J Oral Pathol        ISSN: 0300-9777


  9 in total

1.  Cytokeratin polypeptides expression in different epithelial elements of human salivary glands.

Authors:  S Geiger; B Geiger; O Leitner; G Marshak
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  Comparative cytokeratin expression in the different cell types of salivary gland mucoepidermoid carcinoma.

Authors:  Rebeca Souza Azevedo; Oslei Paes de Almeida; Luiz Paulo Kowalski; Fábio Ramôa Pires
Journal:  Head Neck Pathol       Date:  2008-08-08

3.  Salivary gland components involved in the formation of squamous metaplasia.

Authors:  I Dardick; M T Jeans; N M Sinnott; J F Wittkuhn; H J Kahn; R Baumal
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

4.  Comparative histogenesis and morphogenesis of mucoepidermoid carcinoma and pleomorphic adenoma. An ultrastructural study.

Authors:  I Dardick; M R Gliniecki; J G Heathcote; A Burford-Mason
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 5.  Salivary mucoepidermoid carcinoma revisited.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Asterios Triantafyllou; Jennifer L Hunt; Alessandra Rinaldo; Primož Strojan; Missak Haigentz; William M Mendenhall; Robert P Takes; Vincent Vander Poorten; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-26       Impact factor: 2.503

Review 6.  Salivary gland-like tumours of the breast: surgical and molecular pathology.

Authors:  M Pia-Foschini; J S Reis-Filho; V Eusebi; S R Lakhani
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

Review 7.  Myoepithelial cells in pathology.

Authors:  N Balachander; K M K Masthan; N Aravindha Babu; V Anbazhagan
Journal:  J Pharm Bioallied Sci       Date:  2015-04

8.  Immunohistochemical study of salivary gland tumors in a tertiary institution in South-South Region of Nigeria.

Authors:  Olufemi Gbenga Omitola; Cornelius Azekanabo Iyogun
Journal:  J Oral Maxillofac Pathol       Date:  2018 May-Aug

9.  Utility of smooth muscle actin and CD117 as reliable markers in the diagnosis of salivary gland neoplasms.

Authors:  Subhasri Raman; Herald J Sherlin
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.